KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Elevance Health (ELV) Shares Repurchased (2017 - 2025)

Elevance Health (ELV) has disclosed Shares Repurchased for 15 consecutive years, with $471.0 million as the latest value for Q4 2025.

Quarterly Shares Repurchased fell 73.99% to $471.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 billion through Dec 2025, down 10.17% year-over-year, with the annual reading at $2.6 billion for FY2025, 10.17% down from the prior year.
Shares Repurchased for Q4 2025 was $471.0 million at Elevance Health, down from $876.0 million in the prior quarter.
The five-year high for Shares Repurchased was $1.8 billion in Q4 2024, with the low at $60.0 million in Q3 2024.
Average Shares Repurchased over 5 years is $619.8 million, with a median of $555.5 million recorded in 2022.
The sharpest move saw Shares Repurchased crashed 87.5% in 2024, then soared 1360.0% in 2025.
Over 5 years, Shares Repurchased stood at $522.0 million in 2021, then increased by 8.81% to $568.0 million in 2022, then skyrocketed by 63.38% to $928.0 million in 2023, then surged by 95.15% to $1.8 billion in 2024, then tumbled by 73.99% to $471.0 million in 2025.
According to Business Quant data, Shares Repurchased over the past three periods came in at $471.0 million, $876.0 million, and $378.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.